Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
22 Mars 2024 - 4:12PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Schedule
14A
Proxy
Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐ |
Preliminary Proxy Statement |
|
|
☐ |
Confidential, for Use of the Commission Only (as permitted
by Rule 14a-6(e)(2)) |
|
|
☐ |
Definitive Proxy Statement |
|
|
☒ |
Definitive Additional Materials |
|
|
☐ |
Soliciting Material under § 240.14a-12 |
THARIMMUNE,
INC.
(Name
of Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment
of Filing Fee (Check all boxes that apply):
☒ |
No fee required |
|
|
☐ |
Fee paid previously with preliminary materials. |
|
|
☐ |
Fee computed on table in exhibit required by Item 25(b)
per Exchange Act Rules 14a- 6(i)(1) and 0-11 |
Hillstream BioPharma (NASDAQ:HILS)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Hillstream BioPharma (NASDAQ:HILS)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024